Stock BIO3 BIOTEST AG
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Biotest AG Deutsche Boerse AG

Equities

BIO3

DE0005227235

Real-time Estimate Tradegate
Other stock markets
 04:30:00 2024-06-20 EDT 		5-day change 1st Jan Change
26.7 EUR +0.75% Intraday chart for Biotest AG +3.11% -13.96%
06-17 Biotest Receives FDA Approval for Innovative Yimmugo Immunoglobulin to Treat Primary Immunodeficiencies CI
05-07 Biotest Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CSL LIMITED Stock CSL Limited
 94.45B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 38.9B
BIOGEN INC. Stock Biogen Inc.
 32.56B
UCB Stock UCB
 28.34B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 15.98B
  1. Stock Market
  2. Equities
  3. BIO3 Stock
  4. BIO3 Stock
  5. Charts Biotest AG
  6. Sector Chart